Skip to main content

Gold Mitchell

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Gold Mitchell as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ALPN Alpine Immune Sciences, Inc.

Executive Chairman and CEO7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 29, 2023 (view filing)Dec 281 dayGold MitchellExecutive Chairman and CEOSSale−1.02K$20.04−$20.4K−100.0%0 after10b5-1
Dec 27, 2023 (view filing)9:07 PM ETDec 22-275 daysGold MitchellExecutive Chairman and CEOSSale−91.9K$20.25−$1.86M−100.0%0 after3 lots10b5-1
Dec 21, 2023 (view filing)7:34 PM ETDec 192 daysGold MitchellExecutive Chairman and CEOSSale−2.40K$20.01−$48.1K−100.0%0 after10b5-1
Dec 12, 2023 (view filing)9:02 PM ETDec 8-124 daysGold MitchellExecutive Chairman and CEOSSale−118.0K$17.27−$2.04M−100.0%0 after4 lots10b5-1
Sep 21, 2021 (view filing)Sep 174 daysGold MitchellExecutive Chairman and CEOSSale−400.0K$9.40−$3.76M−13.3%2.60M afterDuplicate filing
Sep 21, 2021 (view filing)Sep 174 daysGold MitchellExecutive Chairman and CEOSSale−45.3K$10.01−$453.1K−29.3%109.4K after
Sep 17, 2021 (view filing)Sep 15-162 daysGold MitchellExecutive Chairman and CEOSSale−10.3K$10.00−$102.5K−6.2%154.6K after2 lots